Champlain Investment Partners LLC Has $133.61 Million Stock Position in The Cooper Companies, Inc. $COO

Champlain Investment Partners LLC lowered its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 5.9% in the 3rd quarter, Holdings Channel.com reports. The fund owned 1,948,834 shares of the medical device company’s stock after selling 121,981 shares during the period. Champlain Investment Partners LLC’s holdings in Cooper Companies were worth $133,612,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. CYBER HORNET ETFs LLC acquired a new stake in Cooper Companies in the second quarter valued at $36,000. MUFG Securities EMEA plc acquired a new position in Cooper Companies during the 2nd quarter worth about $42,000. Assetmark Inc. grew its position in shares of Cooper Companies by 357.8% in the 2nd quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock valued at $44,000 after buying an additional 483 shares during the last quarter. Quent Capital LLC bought a new stake in shares of Cooper Companies in the 3rd quarter valued at about $44,000. Finally, Mather Group LLC. acquired a new stake in shares of Cooper Companies in the third quarter valued at about $56,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.3%

NASDAQ:COO opened at $83.92 on Tuesday. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $92.84. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $16.37 billion, a price-to-earnings ratio of 44.64, a PEG ratio of 2.39 and a beta of 1.02. The firm has a fifty day simple moving average of $82.27 and a two-hundred day simple moving average of $75.80.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.06 billion. During the same quarter in the prior year, the firm earned $1.04 EPS. The business’s revenue was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently commented on COO shares. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday. JPMorgan Chase & Co. raised their price target on shares of Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a report on Friday, December 5th. Weiss Ratings raised shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th. Stifel Nicolaus set a $95.00 price objective on shares of Cooper Companies and gave the stock a “buy” rating in a research report on Friday, December 5th. Finally, Wells Fargo & Company lifted their target price on shares of Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a research note on Friday, December 5th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $90.77.

Insider Transactions at Cooper Companies

In other Cooper Companies news, Director Cynthia L. Lucchese purchased 1,784 shares of Cooper Companies stock in a transaction that occurred on Monday, December 22nd. The stock was acquired at an average price of $84.06 per share, with a total value of $149,963.04. Following the transaction, the director owned 9,445 shares in the company, valued at $793,946.70. This trade represents a 23.29% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Maria Rivas purchased 1,000 shares of the firm’s stock in a transaction on Thursday, December 18th. The shares were acquired at an average price of $82.13 per share, with a total value of $82,130.00. Following the purchase, the director directly owned 11,141 shares in the company, valued at $915,010.33. This represents a 9.86% increase in their position. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have acquired 16,014 shares of company stock valued at $1,304,416. Company insiders own 2.08% of the company’s stock.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.